0001575872-23-000658 Sample Contracts

MDNA LIFE SCIENCES, INC. West Palm Beach, FL 33411

Agreement to Convert Deferred Compensation to Common Stock • May 2nd, 2023 • MDNA Life Sciences, Inc. • In vitro & in vivo diagnostic substances

• Contract Type
  Agreement to Convert Deferred Compensation to Common Stock
• Filed
  May 2nd, 2023
• Company
  MDNA Life Sciences, Inc.
• Industry
  In vitro & in vivo diagnostic substances

You are being sent this letter (the “Letter Agreement”) as you (the “Holder”), as of December 31, 2022 are owed $358,133 of deferred compensation (the “Debt”) by MDNA Life Sciences Inc. (the “Company”).